CN108410775A - One plant height produces farnoquinone(MK-7)Bafillus natto and its application - Google Patents

One plant height produces farnoquinone(MK-7)Bafillus natto and its application Download PDF

Info

Publication number
CN108410775A
CN108410775A CN201810392873.XA CN201810392873A CN108410775A CN 108410775 A CN108410775 A CN 108410775A CN 201810392873 A CN201810392873 A CN 201810392873A CN 108410775 A CN108410775 A CN 108410775A
Authority
CN
China
Prior art keywords
natto
farnoquinone
bacillus subtilis
bafillus natto
bafillus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201810392873.XA
Other languages
Chinese (zh)
Other versions
CN108410775B (en
Inventor
李会
徐行
刘瑞涵
史劲松
许正宏
张晓梅
龚劲松
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangnan University
Original Assignee
Jiangnan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangnan University filed Critical Jiangnan University
Priority to CN201810392873.XA priority Critical patent/CN108410775B/en
Publication of CN108410775A publication Critical patent/CN108410775A/en
Application granted granted Critical
Publication of CN108410775B publication Critical patent/CN108410775B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07Bacillus
    • C12R2001/125Bacillus subtilis ; Hay bacillus; Grass bacillus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/66Preparation of oxygen-containing organic compounds containing the quinoid structure

Abstract

The invention discloses the bafillus natto of plant height production farnoquinone (MK 7) and its applications, belong to microorganism field.1 A27 of bafillus natto (Bacillus subtilis natto) ND of the present invention are preserved in China typical culture collection center on March 14th, 2018, and preservation address is Wuhan, China Wuhan University, and deposit number is CCTCC NO:M 2018131.The yield of farnoquinone (MK 7) is greatly improved, yield about 70mg/L, and 3 days are only needed to can reach maximum production, substantially reduce fermentation period, time cost is saved, industrial fermentation production is can be applied to and the bacterial strain genetic stability is good, 5 generation of continuous passage, its production farnoquinone (MK 7) yield was basicly stable, same higher level is maintained, it can be as the production bacterial strain further researched and developed.

Description

One plant height produces bafillus natto and its application of farnoquinone (MK-7)
Technical field
The present invention relates to the bafillus natto of plant height production farnoquinone (MK-7) and its applications, belong to microorganism neck Domain.
Background technology
Farnoquinone (menaquinone, MK) is a kind of liposoluble vitamin, the naphthoquinones base with phylloquinone bioactivity The derivative of group, is one of indispensable important vitamin in human body.Farnoquinone is aphthoquinone series compound, yellowish Color crystal shares 14 kinds of forms according to the length difference of C-3 isoprene side chains on its molecular structure, indicates to refer to MK-n The number of isoprene unit on side chain), wherein MK-7 (Agua-Mephyton 2) bioactivity is the most notable.
Farnoquinone (MK-7) is mainly based on chemical synthesis at present, but there are precursor raw materials for conventional chemical synthesis Source limitation, a large amount of isomers of chemical reaction generation, by-product is more, low yield, brings the problems such as environmental pollution, and the dimension synthesized Raw element K2, isoprene side chains are mostly cis-structures, and activity is relatively low.And it is mostly that fermentation method is made that activity is highest.Therefore, micro- Biological fermentation process prepares farnoquinone and increasingly receives an acclaim, and the industrialized production of vitamin is carried out using microbe fermentation method Great advantage be:Production process can be greatly simplified and improve working conditions, reduce environmental pollution while being also beneficial to resource Exploitation and comprehensive utilization.But the yield of existing strain fermentation production farnoquinone is relatively low, fermentation level is relatively low, from And cause cost excessively high.This is a main cause of restricted fermentation production farnoquinone development.In addition, current strain fermentation The fermentation period for producing farnoquinone is also all longer, needs 6 days or more, time cost is larger.Therefore, breeding high-yield bacterial strain is ground Study carefully strain characteristic and fermentation behavior has important scientific value for improving the production performance of fermenting and producing farnoquinone.
A kind of new and effective new approaches of physical mutagenesis --- helium atmospheric pressure at room plasma mutation breeding technologies are wide at present The general mutagenic and breeding applied to bacterial strain.Using high-purity helium as working gas, generated under normal temperature and pressure state high-energy it is equal from Daughter, the high-energy chemistry active particle being rich in can generate bacterial strain the loss of high intensity inhereditary material, and then be opened using cell Dynamic SOS high serious forgiveness repair mechanisms, generate the mismatch site of wide variety, it is abundant to ultimately form inheritance stability, type Mutant strain.Therefore it is applied among the mutagenic and breeding of farnoquinone production bacterial strain with important value.
Invention content
Technical problem to be solved by the present invention lies in provide a kind of natto of biofermentation high yield farnoquinone (MK-7) The mutagenic strain of bacillus (Bacillus subtilis natto), and produce farnoquinone using the strain fermentation (MK-7) method can reach the requirement of efficiently production farnoquinone (MK-7).
The present invention is to solve above-mentioned technical problem by the following technical programs:
The first purpose of the invention is to provide the bafillus natto (Bacillus of plant height production farnoquinone (MK-7) Subtilis natto) ND-1-A27, it is preserved in China typical culture collection center, preservation address on March 14th, 2018 For Wuhan, China Wuhan University, deposit number is CCTCC NO:M 2018131.
Second object of the present invention is to provide the bafillus natto ND-1-A27 in fermenting and producing farnoquinone (MK-7) application in.
In one embodiment of the invention, the application is from bafillus natto ND-1-A27 fermentations 3~6 Farnoquinone (MK-7) is extracted in its obtained zymotic fluid.
Third object of the present invention is to provide the bafillus natto ND-1-A27 fermenting and producing farnoquinones (MK- 7) method, the method are that the cellular liquid culture of above-mentioned bacterial strains is seeded in fermentation with the inoculum concentration of 2~4% (w/w) In culture medium, at 35~38 DEG C, fermented and cultured 3~6 days under the conditions of stationary culture.
In one embodiment of the invention, the fermentation medium components are 40~60g/L of glycerine;Yeast powder 40~ 60g/L;180~200g/L of soy peptone;0.5~0.8g/L of dipotassium hydrogen phosphate.
Fourth object of the present invention is to provide the microbial bacterial agent for including the bafillus natto ND-1-A27.
In one embodiment of the invention, the microbial bacterial agent is solid-state microbial inoculum or liquid microbial inoculum.
Fifth object of the present invention is to provide the food, the medicines that are prepared using the bafillus natto ND-1-A27 Product or health products.
Sixth object of the present invention is to provide the bafillus natto ND-1-A27 in food, drug or health products Application.
Beneficial effects of the present invention:
The present invention provides a kind of bafillus natto (Bacillus of biofermentation high yield farnoquinone (MK-7) Subtilis natto) mutagenic strain, and using the strain fermentation production farnoquinone (MK-7) method, significantly carry The high yield of farnoquinone (MK-7).And since strain growth speed is fast after mutagenesis, growth fermentation period is greatly shortened, is saved Time cost, can be applied to industrial fermentation production and the bacterial strain genetic stability is good, and 5 generation of continuous passage, it produced vitamin K2 (MK-7) yield is basicly stable, maintains same higher level, can be as the production bacterial strain further researched and developed.It is raw Object material preservation
Bafillus natto (Bacillus subtilis natto) ND-1-A27, on March 14th, 2018 is preserved in State's Type Tissue Collection, preservation address are Wuhan, China Wuhan University, and deposit number is CCTCC NO:M 2018131.
Description of the drawings
Fig. 1 is bafillus natto (Bacillus subtilis natto) ND-1 of the present invention on nutrient agar Colonial morphology;
Fig. 2 is bafillus natto (the Bacillus subtilis natto) bats of ND-1 under the microscope of the present invention Take the photograph image;
Fig. 3 is the lethality curve in the present invention;
Fig. 4 is the Yield comparison of mutagenic strain in the present invention;
Fig. 5 is the research of mutagenic strain fermentation period in the present invention;
Fig. 6 is the genetic stability result figure of bafillus natto mutagenic fungi.
Specific implementation mode
The present invention is further described with reference to embodiment, the present invention is not limited only to the embodiment.
Embodiment 1:The separation of initial strains bafillus natto (Bacillus subtilis natto) ND-1 identify with And the preservation of bacterial strain
(1) separation, screening of bafillus natto (Bacillus subtilis natto) ND-1
The present invention buys natto from market, weighs 1.0-2.0g soil samples in 250mL triangular flasks, with 10-50mL physiology salts Then aqueous suspension carries out gradient dilution, take 0.1mL dilutions to be coated on nutrient agar panel and cultivated.Under the conditions of 37 DEG C After cultivating 8h, chooses the preferable single bacterium colony of growing way and carry out fermentation verification.Picking single bacterium colony is inoculated into fresh liquid seeds culture Base, 37 DEG C, 90-120r/min culture 8h, then trained with the fermentation that the inoculum concentration access liquid amount of 2% (w/w) is 30mL/250mL It supports base, 37 DEG C, ferment 3-6 days under the conditions of stationary culture, collects zymotic fluid, organic film process with 0.22 μm is extracted through extractant Afterwards, using high performance liquid chromatography detection farnoquinone (MK-7) production concentration.
(2) identification of bafillus natto (Bacillus subtilis natto) ND-1
After carrying out morphological observation, Physiology and biochemistry identification and the analysis of 16s rDNA strain idenfications to the bacterial strain, ND- is identified 1 is bafillus natto.Specific qualification result is as follows:
Morphological observation:Bacterium colony is canescence, and subcircular, dry tack free is opaque, there is fold, and matt, edge is not only It slides into decomposite leaf shape, central color is deeper than marginal portion (such as Fig. 1);To cultivating bacterial strain progress individual morphology observation for 24 hours, bacterium is found Strain Gram's staining is positive, rod-short, both ends blunt circle (such as Fig. 2).
Physiology and biochemistry is identified:Several physiological and biochemical tests have been carried out respectively to the bacterial strain isolated, including Gram's staining, Catalase, V-P measurement, V-P cultures, pH measurement, gelatin liquefaction, Starch Hydrolysis, D-Glucose fermentation, D- wood-sugar fermentations, D- The experiments such as mannose ferment, the growth of NaCl salt tolerants, nitrate reduction.It is compareed with bacillus subtilis to increase in qualification process The accuracy of qualification result judgement.The characteristics such as the production Nattokinase and synthesis γ-PGA that have in conjunction with it, are further determined as Bafillus natto.
16s rDNA strain idenfications:Bafillus natto (Bacillus subtilis are extracted by genomic kit Natto) the full-length genome of ND-1 bacterial strains transfers the 16s rDNA segments of the bacterial strain using universal primer 27F and 1492R, sequencing As a result in being compared on NCBI.
Embodiment 2:Preliminary screening is carried out to mutagenic strain to ND-1 mutagenesis and using analogue using ARTP
(1) preparation of bacteria suspension
Bafillus natto (Bacillus subtilis natto) ND-1 bacterial strains one on picking nutrient agar Ring is seeded in the 250mL conical flasks equipped with 30mL seed culture mediums, at 37 DEG C, is placed on shaking table and is turned with 120r/min Speed culture 8h is centrifuged and thalline is suspended with physiological saline to logarithmic phase.Thalline OD values are suitably diluted to physiological saline to exist Between 0.8-1.2, metal slide glass is placed in alcolhol burner flame envelope calcination in super-clean bench, sterilized glass plate is put into after cooling In, it takes bacteria suspension to be uniformly applied to slide glass, without air-drying, carries out mutagenesis.
(2) ARTP mutagenesis
Ultraviolet sterilization is first opened in mutagenesis system operation storehouse, then is put slide glass to mutagenesis system with aseptic nipper and operated storehouse, is adjusted Knob below microscope carrier, makes slide glass be at flow ports.Setting instrument power is 100W, throughput parameter is 10SLM, with mutagenesis Time is variable element, and mutation time is respectively 0s, 10s, 20s, 30s, 40s, 50s.Sample treatment finishes, and slide glass is put to dress Have in the pipe of physiological saline, shakes, natto bacillus subtilis is eluted in liquid, new bacteria suspension is formed.After handling Bacteria suspension carry out gradient dilution apply tablet, make lethality curve be illustrated in fig. 3 shown below, as can be seen from the figure when mutagenic treatment Between there are apparent dose-effect relationships between bacterial strain lethality, with the extension of processing time, lethality gradually rises.
(3) resistance screening of analogue
The structure of the farnoquinone precursor substance (DHNA) containing 90mg/L will be coated on after above-mentioned bacteria suspension gradient dilution On the solid medium of analog 1,4-dihydroxy-2-naphthsaisyuoic acid (HNA), 37 DEG C of incubator overnight incubations are placed in, obtain 31 Single bacterium colony.
Embodiment 3:Utilize the strain fermentation production farnoquinone (MK-7) after mutagenesis preliminary screening
(1) the cellular liquid culture of mutagenic strain is prepared
31 plants of mutagenic strains and initial strains natto gemma bar on the picking base of resistance culture containing analogue respectively Bacterium (Bacillus subtilis natto) ND-1 is seeded in the 250mL conical flasks equipped with 30mL seed culture mediums, at 37 DEG C Under, the rotating speed culture 8h on shaking table with 120r/min is placed in logarithmic phase, obtains the cellular liquid culture of mutagenic strain.
(2) ingredient of fermentation medium and proportioning are:
Glycerine 50g/L;Yeast powder 50g/L;Soy peptone 189g/L;Dipotassium hydrogen phosphate 0.6g/L;121 DEG C of high steams Lower sterilizing 20min.
(3) shake flask fermentation:
The cellular liquid culture of above-mentioned bacterial strains is seeded in the inoculum concentration of 2% (w/w) and is sent out equipped with sterilized 30mL In the 250mL conical flasks of ferment culture medium, at 37 DEG C, fermented and cultured 6 days, obtain zymotic fluid under the conditions of stationary culture.
(4) product detection:
By above-mentioned zymotic fluid extractant (n-hexane:Isopropanol=2:1) it extracts 3 times, is blown extractant using nitrogen evaporator It is dry, and redissolved using methanol, then cleaned by 0.22 μm of organic membrane filter, filtrate utilizes high-efficient liquid phase chromatogram technique analysis dimension life The content of plain K2 (MK-7).It is made to volume analysis figure such as Fig. 4 of initial strains and 31 plants of mutagenic strains.Wherein number 1 is Initial strains, 2 to 32 bacterial strains obtained for mutagenesis screening.It then obtains No. 27 producing strains of number to protrude, reaches 69.76mg/L, about It is the 320% of original strain yield.It is named as bafillus natto ND-1-A27, is preserved in on March 14th, 2018 China typical culture collection center, preservation address are Wuhan, China Wuhan University, and deposit number is CCTCC NO: M2018131。
Embodiment 4:The fermentation period of bacterial strain ND-1-A27 is probed into
Bacterial strain ND-1-A27 through the authenticated high yield farnoquinone (MK-7) of embodiment 3 is subjected to shaking flask continuously culture 6 It, samples, studies the variation of biomass and yield in its fermentation process daily.Following attached drawing 5, then it can be obtained from the figure that, in fermentation two It when, thalline content has reached highest, and yield terminates to have tended towards stability in third day, therefore fermentation period only needs 3 days.
Embodiment 5:The genetic stability of bacterial strain ND-1-A27 is verified
Bacterial strain ND-1-A27 through the authenticated high yield farnoquinone (MK-7) of embodiment 3 is subjected to shaking flask continuously culture 5 Generation, to detect its genetic stability.Fermentability is measured after shake flask fermentation, is control with well-grown primary bacterial strain.Bacterium Strain passage fermenting experiment result is illustrated in fig. 6 shown below.As seen from the figure, bacterial strain ND-1-A27 passages have no significant effect fermentation level, Its produce farnoquinone (MK-7) ability it is basicly stable, maintain same higher level, to show bacterial strain ND-1-A27 have compared with Good inheritance stability characteristic.
Although the present invention has been described by way of example and in terms of the preferred embodiments, it is not limited to the present invention, any to be familiar with this skill The people of art can do various change and modification, therefore the protection model of the present invention without departing from the spirit and scope of the present invention Enclosing be subject to what claims were defined.

Claims (9)

1. a plant height produces the bafillus natto Bacillus subtilis natto ND-1-A27 of farnoquinone (MK-7), It is characterized in that, the bafillus natto Bacillus subtilis natto ND-1-A27 were in preservation on March 14 in 2018 In China typical culture collection center, preservation address is Wuhan, China Wuhan University, and deposit number is CCTCC NO:M 2018131。
2. bafillus natto Bacillus subtilis natto ND-1-A27 described in claim 1 are tieed up in fermenting and producing Application in raw element K2 (MK-7).
3. application according to claim 2, which is characterized in that the application is from the bacillus natto to ferment 3~6 Farnoquinone (MK-7) is extracted in its obtained zymotic fluid.
4. bafillus natto Bacillus subtilis natto ND-1-A27 fermenting and producings dimension life described in claim 1 The method of plain K2 (MK-7), which is characterized in that the method is by the cellular liquid culture of above-mentioned bacterial strains with 2~4% (w/w) Inoculum concentration inoculation in the fermentation medium, at 35~38 DEG C, fermented and cultured 3~6 days under the conditions of stationary culture.
5. according to the method described in claim 4, it is characterized in that, the fermentation medium components are 40~60g/L of glycerine;Ferment 40~60g/L of female powder;180~200g/L of soy peptone;0.5~0.8g/L of dipotassium hydrogen phosphate.
6. a kind of micro- comprising bafillus natto Bacillus subtilis natto ND-1-A27 described in claim 1 Bacteria agent.
7. microbial bacterial agent according to claim 6, which is characterized in that the microbial bacterial agent is solid-state microbial inoculum or liquid Microbial inoculum.
8. being prepared using bafillus natto Bacillus subtilis natto ND-1-A27 described in claim 1 Food, drug or health products.
9. bafillus natto Bacillus subtilis natto ND-1-A27 described in claim 1 are in food, drug Or the application in health products.
CN201810392873.XA 2018-04-27 2018-04-27 One plant height produces bafillus natto and its application of farnoquinone (MK-7) Active CN108410775B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810392873.XA CN108410775B (en) 2018-04-27 2018-04-27 One plant height produces bafillus natto and its application of farnoquinone (MK-7)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810392873.XA CN108410775B (en) 2018-04-27 2018-04-27 One plant height produces bafillus natto and its application of farnoquinone (MK-7)

Publications (2)

Publication Number Publication Date
CN108410775A true CN108410775A (en) 2018-08-17
CN108410775B CN108410775B (en) 2019-10-25

Family

ID=63137166

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810392873.XA Active CN108410775B (en) 2018-04-27 2018-04-27 One plant height produces bafillus natto and its application of farnoquinone (MK-7)

Country Status (1)

Country Link
CN (1) CN108410775B (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110129234A (en) * 2019-05-27 2019-08-16 沈阳农业大学 The bacillus subtilis strain of high yield Agua-Mephyton 2 through mutagenesis and its application
CN110157654A (en) * 2019-05-21 2019-08-23 江南大学 A kind of bafillus natto recombinant bacterium and its construction method and application
CN110499345A (en) * 2019-09-02 2019-11-26 福建康鸿生物科技有限公司 A kind of fermentation process of vitamin k 2 (MK-7 type)
CN111349639A (en) * 2020-01-17 2020-06-30 西宝生物科技(上海)股份有限公司 High-efficiency biosynthesis vitamin K for improving bacillus natto2(MK-7) method
CN112812986A (en) * 2020-12-21 2021-05-18 苏州微克生活科技有限公司 Bacillus subtilis XTK1001 capable of producing natto kinase and vitamin K2 at high yield and application thereof
CN113564071A (en) * 2021-07-16 2021-10-29 浙江珲达生物科技有限公司 Bacillus natto for producing menadione-7 and application thereof
CN113755404A (en) * 2021-10-13 2021-12-07 华北制药股份有限公司 High-yield strain of vitamin K2(MK-7), screening method thereof and method for producing vitamin K2(MK-7)
CN114231554A (en) * 2021-12-27 2022-03-25 安徽工程大学 Vitamin k2Biosynthesis method of series products

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102808005A (en) * 2012-09-14 2012-12-05 上海红马饲料有限公司 Method for producing vitamin K2 by utilizing bacillus natto
CN103865835A (en) * 2013-12-17 2014-06-18 江南大学 Menadione-7(MK-7) high-yielding strain and application thereof
CN104328064A (en) * 2014-09-16 2015-02-04 丽水双健生物工程有限公司 Bacillus natto and application of Bacillus natto in fermentation production of vitamin K2
CN106701719A (en) * 2017-01-16 2017-05-24 中国科学院合肥物质科学研究院 Method for simultaneously producing vitamin K2 and nattokinase through Bacillus natto fermentation
CN106916810A (en) * 2017-05-04 2017-07-04 南京工业大学 One kind rapidly and efficiently screens farnoquinone(MK‑7)The method of Producing Strain
CN107118991A (en) * 2017-05-25 2017-09-01 山东凤凰生物有限公司 A kind of bafillus natto with the production abilities of MK 7 and its application

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102808005A (en) * 2012-09-14 2012-12-05 上海红马饲料有限公司 Method for producing vitamin K2 by utilizing bacillus natto
CN103865835A (en) * 2013-12-17 2014-06-18 江南大学 Menadione-7(MK-7) high-yielding strain and application thereof
CN104328064A (en) * 2014-09-16 2015-02-04 丽水双健生物工程有限公司 Bacillus natto and application of Bacillus natto in fermentation production of vitamin K2
CN106701719A (en) * 2017-01-16 2017-05-24 中国科学院合肥物质科学研究院 Method for simultaneously producing vitamin K2 and nattokinase through Bacillus natto fermentation
CN106916810A (en) * 2017-05-04 2017-07-04 南京工业大学 One kind rapidly and efficiently screens farnoquinone(MK‑7)The method of Producing Strain
CN107118991A (en) * 2017-05-25 2017-09-01 山东凤凰生物有限公司 A kind of bafillus natto with the production abilities of MK 7 and its application

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
尹聪 等: "纳豆菌微生态制剂的研究进展", 《新进展》 *

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110157654A (en) * 2019-05-21 2019-08-23 江南大学 A kind of bafillus natto recombinant bacterium and its construction method and application
CN110129234A (en) * 2019-05-27 2019-08-16 沈阳农业大学 The bacillus subtilis strain of high yield Agua-Mephyton 2 through mutagenesis and its application
CN110499345A (en) * 2019-09-02 2019-11-26 福建康鸿生物科技有限公司 A kind of fermentation process of vitamin k 2 (MK-7 type)
CN110499345B (en) * 2019-09-02 2021-05-28 福建康鸿生物科技有限公司 Fermentation method of vitamin k2(MK-7 type)
CN111349639A (en) * 2020-01-17 2020-06-30 西宝生物科技(上海)股份有限公司 High-efficiency biosynthesis vitamin K for improving bacillus natto2(MK-7) method
CN112812986A (en) * 2020-12-21 2021-05-18 苏州微克生活科技有限公司 Bacillus subtilis XTK1001 capable of producing natto kinase and vitamin K2 at high yield and application thereof
CN113564071A (en) * 2021-07-16 2021-10-29 浙江珲达生物科技有限公司 Bacillus natto for producing menadione-7 and application thereof
WO2023284853A1 (en) * 2021-07-16 2023-01-19 湖北美琪健康科技有限公司 Bacillus natto for producing menaquinone-7 and use thereof
CN113564071B (en) * 2021-07-16 2023-02-17 湖北美琪健康科技有限公司 Bacillus natto for producing menadione-7 and application thereof
CN113755404A (en) * 2021-10-13 2021-12-07 华北制药股份有限公司 High-yield strain of vitamin K2(MK-7), screening method thereof and method for producing vitamin K2(MK-7)
CN114231554A (en) * 2021-12-27 2022-03-25 安徽工程大学 Vitamin k2Biosynthesis method of series products
CN114231554B (en) * 2021-12-27 2023-07-28 安徽工程大学 Vitamin k 2 Biosynthesis method of serial products

Also Published As

Publication number Publication date
CN108410775B (en) 2019-10-25

Similar Documents

Publication Publication Date Title
CN108410775B (en) One plant height produces bafillus natto and its application of farnoquinone (MK-7)
CN107699500A (en) The method of aureobasidium pullulans and its fermenting and producing pulullan polysaccharide
CN104694424B (en) One plant of Bacillus amyloliquefaciens strain for being isolated from producing protease in fermented soya bean
CN103451133B (en) Bacillus circulans and application for same in preparation for ferulic acid decarboxylase
CN108624524A (en) The bacterial strain and its separating screening method of one plant of production bacteria cellulose
CN106916810A (en) One kind rapidly and efficiently screens farnoquinone(MK‑7)The method of Producing Strain
CN109609491A (en) It is a kind of it is efficient produce kasugarnycin streptomyces microaureus mutagenesis and screening technique
CN103849581B (en) Raw brevibacterium and screen purification process and purposes in a kind of Pericarpium Zanthoxyli
CN116286545B (en) Rhodobacter sphaeroides mutant strain HCYJ-01 and application thereof
CN109169712A (en) A kind of compound biocontrol fungicide and its preparation method and application
CN106434446B (en) One plant of anti-antimony bacterium NXH3 and its application
CN104450571A (en) Bacillus thuringiensis strain for efficient degradation of fly larvae protein
CN116731916A (en) Salt-tolerant bacillus megaterium and application thereof
CN105505798A (en) Endophytic fungus for generating ergosterol and application of endophytic fungus
CN113337432B (en) Methylophilus for producing pyrroloquinoline quinone and application thereof
CN109112171A (en) A kind of preparation method of the antibacterial substance based on marine microorganism
CN102344901B (en) Screening method of bacillus subtilis with sodium chloride tolerance
CN105176895B (en) A kind of bacillus amyloliquefaciens and its application for preventing cotton verticillium wilt
CN111154679B (en) Efficient fermentation method of aflatoxin degradation bacteria
CN109810918B (en) Bacillus atrophaeus with effect of preventing wolfberry leaf blight, biological agent and application of biological agent
CN102936575B (en) Escherichia coli LL016 and application thereof
CN108165514B (en) Bacillus and fermentation product and application thereof
CN102382787B (en) Corynebacterium pekinense and application thereof
CN112391312A (en) Streptomyces and application thereof in prevention and treatment of plant oomycete diseases
CN105586292B (en) One bacillus and its application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant